Why the study?
What are the indications and optimal selection strategies for vasoactive agents in the management of acute heart failure in pediatric patients?
What are the indications and optimal selection strategies for vasoactive agents in the management of acute heart failure in pediatric patients?
This consensus statement provides an evidence-based review of pharmacotherapies for acute heart failure in pediatric cardiac intensive care, emphasizing tailored application based on circulatory physiology.
Clinicians should apply physiology-tailored vasoactive strategies in pediatric acute heart failure; extends evidence synthesis for CICU pharmacotherapy.
No abstract was published with this document — society guidelines, consensus pathways, and scientific statements are typically released without one. See the Key Points and the linked PDF for the full content.
No takes yet. Share an insight, caveat, or question.
Tume et al. (2016) conducted a review in Acute heart failure. Vasoactive agents and pharmacotherapies was evaluated.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: